Cargando…
Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor
Osteosarcoma is the most common primary malignancy of bone in children, adolescents, and adults. Despite extensive surgery and adjuvant aggressive high-dose systemic chemotherapy with potentially severe bystander side effects, cure is attainable in about 70% of patients with localized disease and on...
Autores principales: | Federman, Noah, Chan, Jason, Nagy, Jon O., Landaw, Elliot M., McCabe, Katelyn, Wu, Anna M., Triche, Timothy, Kang, HyungGyoo, Liu, Bin, Marks, James D., Denny, Christopher T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447386/ https://www.ncbi.nlm.nih.gov/pubmed/23024593 http://dx.doi.org/10.1155/2012/126906 |
Ejemplares similares
-
ALCAM-EGFR interaction regulates myelomagenesis
por: Luo, Hongmei, et al.
Publicado: (2021) -
Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
por: Jeong, Young Ju, et al.
Publicado: (2018) -
ALCAM Makes It All Calm by Inhibiting Apoptosis
por: Chen, Peter, et al.
Publicado: (2022) -
ALCAM regulates multiple myeloma chemoresistant side population
por: Wang, Fangfang, et al.
Publicado: (2022) -
ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012)